Assessment of risk factors for osteopenia development in premature babies

Authors

DOI:

https://doi.org/10.34287/MMT.4(59).2023.4

Abstract

Neonatal osteopenia (KB 61.3 (ICD-11)) – violation of mineral exchange of bone tissue (BT) of premature babies (PB). Predicting and detection of osteopenia is the key to its successful control.

Aim. The aim of the article was to determine risk factors influencing the formation of neonatal osteopenia of PB and during the term of intensive care / postintensive nursing.

Materials and methods. Ultrasound densitometer Sunlight Omnisense 9000 was used to measure the ultrasound speed in BT (SOS, m/s) with estimation Z-score (SD) according to gestational age of 56 PB and 20 mature babies (control group) in the early neonatal age. Verification of osteopenia was carried out under the WHO guidelines for radiation methods by Z-score indicator less than SD by -1.0. Estimation of Z-score -2.0 SD and less was attributed to ultra-low indicators. The characteristics of obstetric and gynecological, somatic anamnesis and pregnancy course of premature babies’ mothers, factors of PB postnatal development that influence the formation of BT were studied.

Results. Children born at 33 weeks or earlier are 3.23 times more likely (OR = 3.23; CI 95 % [1.08; 9.70]) to develop BT demineralization by the corresponding term of birth than other PB. The chances of ultra-low SOS by Z-score are 14.22 times higher (OR = 14.22; CI 95 % [3.29; 61.57]) in PB born at 32 weeks of gestation and earlier. Extragenital diseases, clinical signs of calcium deficiency in mothers, and women’s intake of calcium and vitamin D3 during pregnancy did not have a statistically significant difference (p > 0.05) in the studied PB and control group. The mother’s preeclampsia increases the chances of insufficient BT mineralization by 5.47 times (OR = 5.47; CI 95 % [1.07; 27.93]), second parity pregnancy (and subsequent ones) – by 4.51 times (OR = 4.51, CI 95 % [1.38; 14.80]). The factors of the ratio of the duration of mechanical ventilation relative to the total time of PB treatment, the duration of parenteral feeding have an inverse correlation (moderate (r = -0.42, р < 0.05) and significant (r = -0.51, р < 0.05) respectively) with a decrease in SOS to low Z-score.

Conclusions. In PB born at 32 weeks of gestation and earlier, the chances of ultra-low SOS indicators by Z-score are 14.22 times higher (OR = 14.22; CI 95 % [3.29; 61.57]). The following factors predicts insufficient mineralization of BT according to SOS indicators according to the Z-score: mother’s second parity pregnancy (and subsequent ones), preeclampsia, parenteral feeding of PB for more than 8 days (Se = 75.00 %, Sp = 71.87 %, p < 0.0001), duration of mechanical ventilation, which is more than 6.48 % of the total time of PB treatment (Se = 86.67 %, Sp = 59.38 %, p < 0.046).

References

Backström MC, Kuusela AL, Mäki R. Metabolic bone disease of prematurity. Ann Med. 1996;28(4):275-82. doi: 10.3109/07853899608999080

Dursun M, Ozcabi B, Sariaydin M. Factors Affecting Metabolic Bone Disease of Prematurity: Is Hypothyroxinemia Included? Sisli Etfal Hastan Tip Bul. 2022;56(1):84-90. doi: 10.14744/SEMB.2021.99076

[Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care “Parenteral Nutrition Newborn Children”. Order of the Ministry of Health of Ukraine No. 650 on 2022 Apr 18] [Internet]. 2022. [cited 2023 Nov 21]. Ukrainian. Available from: https://www.dec.gov.ua/ wp-content/uploads/2022/04/2022_650_ykpmd_pex_novonar.pdf

Montaner Ramón A. Risk factors of bone mineral metabolic disorders. Semin Fetal Neonatal Med. 2020;25(1):101068. doi: 10.1016/j. siny.2019.101068

Chen W, Yang C, Chen H, Zhang B. Risk factors analysis and prevention of metabolic bone disease of prematurity. Medicine (Baltimore). 2018;97(42):e12861. doi: 10.1097/MD.0000000000012861

Angelika D, Ugrasena IDG, Etika R, Rahardjo P, Bos AF, Sauer PJJ. The incidence of osteopenia of prematurity in preterm infants without phosphate supplementation: A prospective, observational study. Medicine (Baltimore). 2021;100(18):e25758. doi: 10.1097/MD.0000000000025758

Rayannavar A, Calabria AC. Screening for Metabolic Bone Disease of prematurity. Semin Fetal Neonatal Med. 2020;25(1):101086. doi: 10.1016/j. siny.2020.101086

Antipkin YG, Znamenska ET, Marushko1RV, Dudina EA, Lapshin VF, Vlasov AA. [Status of medical care for newborns in Ukraine]. Neonatol Surg Perinat Med. 2020;10(4):5-24. Ukrainian. doi: 10.24061/2413- 4260.x.4.38.2020.1

Faienza MF, D’Amato E, Natale MP, Grano M, Chiarito M, Brunetti G, et al. Metabolic Bone Disease of Prematurity: Diagnosis and Management. Front Pediatr. 2019;7:143. doi: 10.3389/fped.2019.00143

Ukarapong S, Venkatarayappa SKB, Navarrete C, Berkovitz G. Risk factors of metabolic bone disease of prematurity. Early Hum Dev. 2017;112:29-34. doi: 10.1016/j.earlhumdev.2017.06.010

Ramot R, Kachhawa G, Kulshreshtha V, Varshney S, Sankar MJ, Devasenathipathy K, et al. Bone Mass in Newborns Assessed by DXA – A Systematic Review and Meta-analysis. Indian J Endocrinol Metab. 2019;23(2):198-205. doi: 10.4103/ijem.IJEM_681_18

Tong L, Gopal-Kothandapani JS, Offiah AC. Feasibility of quantitative ultrasonography for the detection of metabolic bone disease in preterm infants – systematic review. Pediatr Radiol. 2018;48(11):1537-49. doi: 10.1007/ s00247-018-4161-5

Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, et al. Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin Densitom. 2019;22(4):453-71. doi: 10.1016/j.jocd.2019.07.001

Krithika MV, Balakrishnan U, Amboiram P, Shaik MSJ, Chandrasekaran A, Ninan B. Early calcium and phosphorus supplementation in VLBW infants to reduce metabolic bone disease of prematurity: a quality improvement initiative. BMJ Open Qual. 2022;11(Suppl 1):e001841. doi: 10.1136/ bmjoq-2022-001841

Blanco E, Burrows R, Reyes M, Lozoff B, Gahagan S, Albala C. Breastfeeding as the sole source of milk for 6 months and adolescent bone mineral density. Osteoporos Int. 2017;28(10):2823-30. doi: 10.1007/ s00198-017-4106-0

World Health Organization. Assessment of Fracture Risk and Its Application to Screening and Postmenopausal Osteoporosis [Internet]. Geneva, Switzerland: WHO; 1994 [cited 2023 Nov 25]. Available from: https://apps.who. int/iris/bitstream/handle/10665/39142/WHO_TRS_843_eng.pdf

Skeletal Health Assessment in Children from Infancy to Adolescence. ISCD Official Pediatric Positions [Internet]. ISCD; 2019 [cited 2023 Nov 25]. Available from: https://iscd.org/wp-content/uploads/2021/09/2019-Of-ficial-Positions-Pediatric-1.pdf

Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75(1):25-36. doi: 10.4097/kja.21209

Wang J, Zhao Q, Chen B, Sun J, Huang J, Meng J, et al. Risk factors for metabolic bone disease of prematurity: A meta-analysis. PLoS One. 2022;17(6):e0269180. doi: 10.1371/journal.pone.0269180

Chen W, Zhang Z, Dai S, Xu L. Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia. BMC Pediatr. 2021;21(1):235. doi: 10.1186/s12887- 021-02705-0

Jiang H, Guo J, Li J, Li C, Du W, Canavese F, et al. Artificial Neural Network Modeling to Predict Neonatal Metabolic Bone Disease in the Prenatal and Postnatal Periods. JAMA Netw Open. 2023;6(1):e2251849. doi: 10.1001/ jamanetworkopen.2022.51849

Ritschl E, Wehmeijer K, DE Terlizzi F, Wipfler E, Cadossi R, Douma D, et al. Assessment of skeletal development in preterm and term infants by quantitative ultrasound. Pediatr Res. 2005;58(2):341-6. doi: 10.1203/01. PDR.0000169996.25179.EC

Tansug N, Yildirim SA, Canda E, Ozalp D, Yilmaz O, Taneli F, et al. Changes in quantitative ultrasound in preterm and term infants during the first year of life. Eur J Radiol. 2011;79(3), 428-31. doi: 10.1016/j.ejrad.2010.03.001

Torró-Ferrero G, Fernández-Rego FJ, Gómez-Conesa A. Physical Therapy to Prevent Osteopenia in Preterm Infants: A Systematic Review. Children (Basel). 2021;8(8):664. doi: 10.3390/children8080664

Torró-Ferrero G, Fernández-Rego FJ, Agüera-Arenas JJ, Gomez-Conesa A. Effect of physiotherapy on the promotion of bone mineralization in preterm infants: a randomized controlled trial. Sci Rep. 2022;12(1):11680. doi: 10.1038/s41598-022-15810-6

Avila-Alvarez A, Urisarri A, Fuentes-Carballal J, Mandiá N, Sucasas-Alonso A, Couce ML. Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes. Nutrients. 2020;12(12):3786. doi: 10.3390/nu12123786

Cerar S, Paro-Panjan D, Soltirovska-Šalamon A. The role of quantitative ultrasound in diagnosing severe bone metabolic diseases in newborns. Front Pediatr. 2023;11:1109553. doi: 10.3389/fped.2023.1109553

Published

2023-12-07

How to Cite

Tsymbal, A. Y. ., & Kotlova, Y. V. . (2023). Assessment of risk factors for osteopenia development in premature babies. Modern Medical Technology, (4), 27–36. https://doi.org/10.34287/MMT.4(59).2023.4

Issue

Section

Original research